HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea.

AuthorsAyako Mizota, Kohei Shitara, Takayuki Fukui
JournalJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (J Thorac Oncol) Vol. 6 Issue 3 Pg. 651-2 (Mar 2011) ISSN: 1556-1380 [Electronic] United States
PMID21317750 (Publication Type: Case Reports, Comment, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
Topics
  • Angiogenesis Inhibitors (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Brain Neoplasms (complications, pathology)
  • Dyspnea (diagnosis, etiology)
  • Female
  • Hemangioendothelioma, Epithelioid (diagnosis, drug therapy, etiology)
  • Humans
  • Lung Neoplasms (diagnosis, etiology)
  • Lymphatic Metastasis
  • Middle Aged
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: